Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter

Clinical trial NCT03423979 · COMPLETED

Trial details

NCT number: NCT03423979
Sponsor: Urotronic Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Benign Prostatic Hypertrophy

Start date: 2017-12-19
Primary completion: 2019-06-04
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.